Description
OVERVIEWProduct overview
Thymosin alpha-1 is a peptide originally isolated from thymic tissue and studied for its role in the maturation and function of T lymphocytes.
It appears in immunology literature on antigen presentation, dendritic cell maturation, cytokine profiles and infection models.
Supplied here strictly as a laboratory reference compound.
SUPPLY IN IRELANDThymosin Alpha-1 Ireland — supplied to research laboratories
Research groups across Ireland buy Thymosin Alpha-1 from Kensington Laboratories as a lyophilised Thymosin Alpha-1 peptide, released only against a batch-matched certificate of analysis. Every vial of high purity Thymosin Alpha-1 is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering Thymosin Alpha-1 in Ireland receive material with documented purity and identity.
Laboratory Thymosin Alpha-1 is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning ThymosinAlpha1 research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for Thymosin Alpha-1 peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
Thymosin Alpha-1 is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 5 mg or 10 mg per vial
- CAS number: 62304-98-7
- Peptide class: 28-amino-acid thymic peptide
- Also known as: Tα1, thymalfasin
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
Thymosin alpha-1 is a peptide originally isolated from thymic tissue and studied for its role in the maturation and function of T lymphocytes.
It appears in immunology literature on antigen presentation, dendritic cell maturation, cytokine profiles and infection models.
Supplied here strictly as a laboratory reference compound.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- T-cell maturation and function assays
- Dendritic cell and antigen presentation studies
- Cytokine profiling in immune models
- Infection and immune reconstitution models
Scientific context and proposed mechanisms
Authors most often describe activity through Toll-like receptor signalling on dendritic cells, leading to altered cytokine output and downstream T-cell responses.
The peptide is generally characterised as an immune modulator rather than a direct stimulant of a single pathway.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-THYMOSINAL-2407A
- Testing laboratory
- Janoshik Analytical, s.r.o.
- Date tested
- 2 July 2026
- Reported purity
- 99.38%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
